Tudor Investment Corp
ASND icon

Tudor Investment Corp’s Ascendis Pharma A/S ASND Stock Holding History

Tudor Investment Corp’s Portfolio ASND Stock Details ASND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.43M Buy
+16,625
New +$3.88M 0.01% 1366
2025
Q2 		– Sell
-21,299
Closed -$3.32M – 3225
2025
Q1 		$3.32M Buy
+21,299
New +$3.04M 0.01% 1013
2024
Q4 		– Sell
-25,891
Closed -$3.87M – 2994
2024
Q3 		$3.87M Sell
25,891
-7,484
-22% -$1.01M 0.01% 841
2024
Q2 		$4.55M Buy
+33,375
New +$4.54M 0.02% 693
2023
Q4 		– Sell
-3,413
Closed -$320K – 2353
2023
Q3 		$320K Buy
+3,413
New +$319K ﹤0.01% 1902
2023
Q1 		– Sell
-27,476
Closed -$3.36M – 2386
2022
Q4 		$3.36M Sell
27,476
-4,456
-14% -$517K 0.07% 378
2022
Q3 		$3.3M Buy
31,932
+11,118
+53% +$1.05M 0.07% 348
2022
Q2 		$1.94M Buy
+20,814
New +$1.96M 0.05% 531
2021
Q3 		– Sell
-8,509
Closed -$1.12M – 2435
2021
Q2 		$1.12M Sell
8,509
-10,353
-55% -$1.38M 0.02% 811
2021
Q1 		$2.43M Buy
18,862
+5,990
+47% +$910K 0.05% 436
2020
Q4 		$2.15M Buy
12,872
+8,172
+174% +$1.35M 0.06% 398
2020
Q3 		$725K Buy
4,700
+1,575
+50% +$226K 0.03% 680
2020
Q2 		$462K Buy
+3,125
New +$429K 0.02% 753
2018
Q2 		– Sell
-11,705
Closed -$766K – 1037
2018
Q1 		$766K Buy
11,705
+4,195
+56% +$236K 0.02% 413
2017
Q4 		$301K Buy
7,510
+1,592
+27% +$57.9K 0.01% 799
2017
Q3 		$215K Buy
+5,918
New +$170K 0.01% 933

Other funds holding ASND

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Tudor Investment Corp's ASND Position: Q2 2026 in Review

Tudor Investment Corp opened a new position in Ascendis Pharma A/S (ASND) in Q2 2026: 16,625 shares worth $4.43M. The stake represents 0.01% of the portfolio and ranks #1366 among its holdings. This is a return to the name: Tudor Investment Corp previously reported a position in ASND as recently as Q1 2025.

Tudor Investment Corp first reported a position in ASND in Q3 2017 and has held it in 16 quarters since. The position peaked at $4.55M in Q2 2024. 313 funds tracked by Wall St. Rank hold ASND as of Q2 2026.

  • Tudor Investment Corp held 16,625 shares of Ascendis Pharma A/S worth $4.43M as of Q2 2026.
  • Ascendis Pharma A/S was a new Tudor Investment Corp position in Q2 2026.
  • Ascendis Pharma A/S made up 0.01% of Tudor Investment Corp's portfolio in Q2 2026, its #1366 holding.
  • Tudor Investment Corp first reported a position in Ascendis Pharma A/S in Q3 2017 and has held it in 16 quarters since.
  • Tudor Investment Corp's Ascendis Pharma A/S position peaked at $4.55M in Q2 2024.
  • 313 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2026.

Based on Tudor Investment Corp's 13F filing for Q2 2026, filed 14 Aug 2026.